Amedisys (AMED) Misses Q1 EPS by 1c; Withdraws Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports First Quarter 2020 Financial Results
May 6, 2020 4:15 PM EDTBATON ROUGE, La., May 06, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020.
Three-Month Periods Ended March 31, 2020 and 2019
Net service revenue increased $24.4Â million to $491.7Â million compared to $467.3Â million in 2019.Net income attributable to Amedisys, Inc. of $31.8Â million compared to $31.3Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $0.96 compared to $0.95 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $53.3Â million compared to $54.9Â million in 2019.Adjusted net service revenue of $491.7Â million compared to $467.8Â million in 2019.Adjusted net... More


